Breaking News Instant updates and real-time market news.

RHHBY

Roche

$29.69

-0.02 (-0.07%)

12:45
10/16/16
10/16
12:45
10/16/16
12:45

Genentech's Atezolizumab gets Orphan status for small cell lung cancer

In a notice posted to the agency's website, the FDA designated Genentech's Atezolizumab as an Orphan drug for the treatment of small cell lung cancer. Genentech is a member of the Roche Group. Reference Link

  • 19

    Oct

  • 06

    Nov

  • 10

    Nov

RHHBY Roche
$29.69

-0.02 (-0.07%)

09/01/16
BMOC
09/01/16
NO CHANGE
BMOC
Bristol-Myers has negative read through from Roche data, says BMO Capital
BMO Capital analyst Alex Arfaei says that the positive data on Roche's (RHHBY) TECENTRIQ for second line NSCLC is negative for Bristol-Myers' (BMY) cancer drug, Opdivo. The analyst does not think that TECENTRIQ's results will be superior to that of Opdivo, but he believes that Roche's drug appears to have "a significant" benefit in PD-L1 positive patients." He predicts that Roche's drug could take "meaningful market share, particularly outside of the U.S." The analyst keeps a Market Perform rating on Bristol-Myers.
09/07/16
09/07/16
NO CHANGE

BioLineRx partnering with Roche company in cancer therapy research
BioLineRx (BLRX) has entered into a collaboration with Genentech, a member of the Roche (RHHBY) Group, to support several Phase 1b studies investigating BioLineRx's BL-8040 in combination with Atezolizumab, Genentech's anti-PDL1 cancer immunotherapy, in multiple cancer indications. The Phase 1b studies will evaluate the clinical response, safety and tolerability of the combination of these therapies, as well as multiple pharmacodynamic parameters, in hematologic malignancies and solid tumors. Under the agreement, Genentech will sponsor and conduct several Phase 1b trials in multiple solid cancer indications. In addition, BioLineRx will sponsor and conduct a Phase 1b study in acute myeloid leukemia patients. The studies are designed to evaluate the safety and efficacy of the combination of BL-8040 and Atezolizumab. Upon completion of the studies, both parties will have the option to expand the collaboration to include a pivotal registration study. Additional details of the collaboration were not disclosed.
09/12/16
JEFF
09/12/16
NO CHANGE
Target $57
JEFF
Hold
Jefferies cuts Bristol-Myers price target, upgrades AstraZeneca
Jefferies analyst Jeffrey Holford lowered his price target for Bristol-Myers Squibb (BMY) to $57 from $69 saying the stock is positioned for a "rough mid term ride." The analyst sees a "difficult catalyst" set for Bristol shares with "numerous" upcoming competitor read-outs in non-small cell lung cancer. The market could see worse than expected data from Bristol's CM-026 and CM-568 studies as well as better than expected data from AstraZeneca's (AZN) MYSTIC study and Roche's (RHHBY) Chemo-IO studies in the first half of 2017, Holford tells investors in a research note. He keeps a Hold rating on Bristol and upgraded this morning AstraZeneca to Buy from Hold. Holford prefers Astra for its immunology exposure.
09/27/16
PIPR
09/27/16
NO CHANGE
Target $62
PIPR
Neutral
Bristol-Myers price target lowered to $62 from $65 at Piper Jaffray
Piper Jaffray analyst Richard Purkiss lowered his price target for Bristol-Myers Squibb (BMY) to $62 saying he sees the company ceding Opdivo's early-mover advantage in lung cancer to competitors. The analyst expects to see details from Roche's (RHHBY) positive OAK trial of Tecentriq vs. docetaxel in non-small cell lung cancer at the upcoming ESMO meeting. Purkiss also expects to see details from Merck's (MRK) positive KEYNOTE-024 trial of Keytruda. The analyst lowered his post-2016 Opdivo forecasts and reiterates a Neutral rating on Bristol shares.

TODAY'S FREE FLY STORIES

SANM

Sanmina

$35.45

0.5 (1.43%)

16:09
01/19/18
01/19
16:09
01/19/18
16:09
Earnings
Sanmina reports Q1 preliminary adjusted EPS 48c, consensus 71c »

Reports Q1 preliminary…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

LMT

Lockheed Martin

$332.26

-0.74 (-0.22%)

16:07
01/19/18
01/19
16:07
01/19/18
16:07
Periodicals
Breaking Periodicals news story on Lockheed Martin »

U.S. approves sale of…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 21

    Feb

  • 07

    Mar

CPLA

Capella Education

$80.50

0.7 (0.88%)

, STRA

Strayer

$93.08

0.9 (0.98%)

16:06
01/19/18
01/19
16:06
01/19/18
16:06
Hot Stocks
Capella Education shareholders approve proposed merger with Strayer »

Capella Education (CPLA)…

CPLA

Capella Education

$80.50

0.7 (0.88%)

STRA

Strayer

$93.08

0.9 (0.98%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 19

    Jan

  • 19

    Jan

ADM

Archer Daniels

$40.61

0.13 (0.32%)

, BG

Bunge

$69.78

0.14 (0.20%)

16:03
01/19/18
01/19
16:03
01/19/18
16:03
Periodicals
Archer Daniels made takeover approach to Bunge, WSJ says »

Archer Daniels Midland…

ADM

Archer Daniels

$40.61

0.13 (0.32%)

BG

Bunge

$69.78

0.14 (0.20%)

GLNCY

Glencore

$11.29

-0.02 (-0.18%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 06

    Feb

  • 14

    Feb

C

Citi

$78.16

0.77 (0.99%)

16:01
01/19/18
01/19
16:01
01/19/18
16:01
Conference/Events
Citigroup to hold a conference call »

CFO Gerspach and…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 19

    Jan

  • 24

    Jan

GOLF

Acushnet Holdings

$21.50

0.65 (3.12%)

16:01
01/19/18
01/19
16:01
01/19/18
16:01
Hot Stocks
Acushnet Holdings acquires Linkgs & Kings, terms not disclosed »

Acushnet Holdings…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

BG

Bunge

$69.79

0.145 (0.21%)

, ADM

Archer Daniels

$40.66

0.18 (0.44%)

15:58
01/19/18
01/19
15:58
01/19/18
15:58
Hot Stocks
Breaking Hot Stocks news story on Bunge, Archer Daniels »

Bunge jumps 10% after…

BG

Bunge

$69.79

0.145 (0.21%)

ADM

Archer Daniels

$40.66

0.18 (0.44%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 06

    Feb

  • 14

    Feb

BG

Bunge

$69.76

0.12 (0.17%)

, ADM

Archer Daniels

$40.66

0.18 (0.44%)

15:57
01/19/18
01/19
15:57
01/19/18
15:57
Periodicals
Breaking Periodicals news story on Bunge, Archer Daniels »

Archer Daniels made…

BG

Bunge

$69.76

0.12 (0.17%)

ADM

Archer Daniels

$40.66

0.18 (0.44%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 06

    Feb

  • 14

    Feb

HGT

Hugoton Royalty Trust

15:57
01/19/18
01/19
15:57
01/19/18
15:57
Hot Stocks
Breaking Hot Stocks news story on Hugoton Royalty Trust »

Hugoton Royalty Trust…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

CMCSA

Comcast

$41.85

0.17 (0.41%)

15:50
01/19/18
01/19
15:50
01/19/18
15:50
Options
Bullish option play in Comcast ahead of earnings next week »

Bullish option play in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 24

    Jan

SLB

Schlumberger

$76.33

-0.0384 (-0.05%)

15:35
01/19/18
01/19
15:35
01/19/18
15:35
Recommendations
Schlumberger analyst commentary  »

Schlumberger price target…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 19

    Jan

HGT

Hugoton Royalty Trust

15:35
01/19/18
01/19
15:35
01/19/18
15:35
Hot Stocks
Breaking Hot Stocks news story on Hugoton Royalty Trust »

Hugoton Royalty Trust…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

AVGO

Broadcom

$269.80

3.99 (1.50%)

, QCOM

Qualcomm

$68.05

0.03 (0.04%)

15:31
01/19/18
01/19
15:31
01/19/18
15:31
Periodicals
FTC in place to make second request over Broadcom's Qualcomm bid, Reuters says »

The U.S. Federal Trade…

AVGO

Broadcom

$269.80

3.99 (1.50%)

QCOM

Qualcomm

$68.05

0.03 (0.04%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 06

    Mar

A

Agilent

$73.00

0.81 (1.12%)

15:30
01/19/18
01/19
15:30
01/19/18
15:30
Options
Agilent attracts a vote of confidence as shares reach 17-year highs »

Agilent attracts a vote…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

FBK

FB Financial

$43.80

0.5 (1.15%)

15:23
01/19/18
01/19
15:23
01/19/18
15:23
Conference/Events
FB Financial management to meet with Stephens »

Meetings to be held in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 23

    Jan

ASNA

Ascena Retail

$2.11

-0.01 (-0.47%)

15:20
01/19/18
01/19
15:20
01/19/18
15:20
Options
Ascena Retail attracts upside call buying »

Ascena Retail attracts…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

15:18
01/19/18
01/19
15:18
01/19/18
15:18
Conference/Events
RBC Capital equity strategy analyst holds luncheon meeting »

Equity Strategy Analyst…

$NSD

NASDAQ Market Internals

15:17
01/19/18
01/19
15:17
01/19/18
15:17
Technical Analysis
NASDAQ market internals summary »

Volume is average for…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

$NYE

NYSE Market Internals

15:16
01/19/18
01/19
15:16
01/19/18
15:16
Technical Analysis
NYSE market internals summary »

Volume is average for…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

IWM

iShares Trust Russell 2000 Index Fund

$158.42

1.88 (1.20%)

, RUT

Russell 2000 Index

15:14
01/19/18
01/19
15:14
01/19/18
15:14
Technical Analysis
On The Fly: Weekly technical notes for Russell 2000 »

At time of writing the…

IWM

iShares Trust Russell 2000 Index Fund

$158.42

1.88 (1.20%)

RUT

Russell 2000 Index

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

AKTX

Akari Therapeutics

$3.60

-0.17 (-4.51%)

15:08
01/19/18
01/19
15:08
01/19/18
15:08
Conference/Events
Akari Therapeutics management to meet with William Blair »

Group luncheon to be held…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 22

    Jan

XLY

Consumer Discretionary Sector SPDR

$105.56

0.8668 (0.83%)

, XLV

Health Care Select Sector SPDR

$88.26

0.151 (0.17%)

15:05
01/19/18
01/19
15:05
01/19/18
15:05
Technical Analysis
On The Fly: Weekly technical notes for S&P 500 »

The S&P 500 (SPX) is…

XLY

Consumer Discretionary Sector SPDR

$105.56

0.8668 (0.83%)

XLV

Health Care Select Sector SPDR

$88.26

0.151 (0.17%)

XLE

Energy Select Sector SPDR

$76.30

-0.1821 (-0.24%)

XLK

Technology Select Sector SPDR

$67.69

0.015 (0.02%)

XLI

Industrial Select Sector SPDR

$79.64

0.1772 (0.22%)

XLU

Utilities SPDR

$49.99

-0.15 (-0.30%)

XLP

Consumer Staples Sector SPDR

$58.01

0.615 (1.07%)

SPY

SPDR S&P 500 ETF Trust

$280.02

0.875 (0.31%)

SPX

S&P 500

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

JOUT

Johnson Outdoors

$62.61

-0.71 (-1.12%)

15:04
01/19/18
01/19
15:04
01/19/18
15:04
Initiation
Johnson Outdoors initiated  »

Johnson Outdoors…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 01

    Mar

EPC

Edgewell Personal Care

$58.26

-1.725 (-2.88%)

15:00
01/19/18
01/19
15:00
01/19/18
15:00
Options
Bearish flow in Edgewell Personal Care as shares see relative weakness »

Bearish flow in Edgewell…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 08

    Feb

15:00
01/19/18
01/19
15:00
01/19/18
15:00
General news
Treasury Closing Summary: »

Treasury Closing…

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.